Cargando…
Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19) pandemic, has caused disruption in cancer care and research, changing daily management approach of cancer patients, above all for those affected by lung cancer disease. Unfortunately...
Autores principales: | Casaluce, Francesca, Gridelli, Cesare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867749/ https://www.ncbi.nlm.nih.gov/pubmed/33569328 http://dx.doi.org/10.21037/tlcr-20-640 |
Ejemplares similares
-
Critical points in the management of EGFR-mutated non-small cell lung cancer
por: Casaluce, Francesca, et al.
Publicado: (2022) -
The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not?
por: Gridelli, Cesare, et al.
Publicado: (2020) -
The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target—a narrative review
por: Spagnuolo, Alessia, et al.
Publicado: (2022) -
The Role of Obesity, Body Composition, and Nutrition in COVID-19 Pandemia: A Narrative Review
por: Rossi, Andrea P., et al.
Publicado: (2022) -
Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
por: Gridelli, Cesare, et al.
Publicado: (2011)